Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

BrainLAB opens new gateway to high-dose radiotherapy

This article was originally published in Clinica

Executive Summary

Targeting high-dose radiotherapy at liver and lung tumours is now a possibility using BrainLAB's ExacTrac X-Ray Adaptive Gating system. Such levels of radiation are traditionally difficult to administer to these tumours, due to respiration-induced movement and the risk of damaging sensitive surrounding tissue. But the Munich, Germany-based company has overcome this problem, and has announced the completion of the first patient treatment programme using the system - carried out with its clinical partners AZ-VUB of Brussels, Belgium.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT059898

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel